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Science is an instrument in the competition between nations. Some of the hottest issues in science, technology and innovation policy revolve around comparative national performance. Industrialised nations mobilise science to achieve higher growth and stronger innovation to the detriment of LDCs; Americans worry about losing their edge on the rest of the world; Europe maintains its long-time ambition to overtake the USA and stay ahead of the emerging economies of South East Asia; the Russian science system is said to be failing altogether.
In an earlier paper, we found that the science systems of the world are divided among eight convergence clubs. Each club has a distinctive portfolio, but its relative performance is driven mainly by comparative advantages and local strengths.​[1]​ In this paper we examine the relationship between national patterns of scientific specialisation and comparative advantages. The aim is to find out under which conditions specific or generic science policies are effective in supporting national performance.
Countries have generic and specific comparative advantages in science. Generic advantages pertain to framework conditions and explain why some countries produce more scientific output than others. Specific advantages have their origin in field-specific strengths and weaknesses, many of which have been accumulated over time. Examples are a profusion of exotic ecology (e.g. Brazil), abundant natural resources (e.g. oil in Saudi Arabia), widespread and burdensome disease (e.g. HIV/AIDS in Africa; obesity in the USA), and a strong industrial cluster (e.g. telecommunications in Finland). Generic and specific comparative advantages are related through size. Large countries tend to be less specialised, i.e. more diverse, than small countries. Large countries, particularly wealthy ones, have more resources to distribute among specialisations and are active in a larger number of research areas. Resource-poor countries need to select a niche in which they can compete internationally.
Total scientific output and its distribution across research areas was constructed for 205 countries in 2008, using the five citation databases of the Web of Science and its classification of publications into subject areas, excluding the social sciences and humanities. For each research area, we calculated a Revealed Symmetric Comparative Advantage. Data on the comparative advantages were found in the UN Statistical Databases, the Global Competitiveness Report, IAEA databases, the World Bank’s Worldwide Governance Indicators project, and other sources.
Generic indicators of size, wealth, and development are strong predictors of scientific output. Per capita GDP, per capita GERD, GERD as a percentage of GDP, the number of researchers per million inhabitants – explain between 54% and 75% of variation in per capita scientific output; total GDP explains about 27%. However, we are looking beyond the usual suspects for the interplay between generic and specific comparative advantages. What determines if countries are active and specialised in a research area?
Our initial results relate to thirteen specific comparative advantages. Four are beyond the control of policy makers: ocean access, oil and gas reserves, and biodiversity. Three are within the remit of policy: the presence of synchrotrons, nuclear research reactors, and a space programme. Six represent urgent social needs: the incidence of HIV/AIDS, tuberculosis, malaria, and cancer, the percentage of the population that is undernourished, and the percentage that is over 65 years of age.
For each of comparative advantage, we used independent samples t-tests to identify in which research areas there is a significant difference between countries that have the advantage and those that do not. For the most distinguishing areas, we test whether the difference can be attributed to generic conditions (size, wealth, resource scarcity, governance) or to specific comparative advantages. 
The scientific portfolios of countries with oil or gas reserves, high biodiversity or ocean access are skewed significantly towards predictable research areas. For example, oil and gas favour petroleum engineering; ocean access encourages ocean engineering; high biodiversity favours entomology. Activity is driven by generic framework conditions; specialisation occurs among active countries with fewer resources. Specific advantages shape specialisation patterns where resources are relative scarce.
In areas that are most prominently affected by the advantages within the remit of policy, activity is explained by the availability of resources. There is a vast difference in size and wealth between active and inactive countries. Countries that specialise have lower per capita resources, an indication of resource scarcity and a need for selectiveness. Very nearly all countries with synchrotrons or nuclear research reactors are active in the related research areas (e.g. applied physics, multidisciplinary materials science). Among active countries, those with research facilities are significantly more likely to be specialised than those without. In major research facilities and space programmes size is the key.
For the six indicators of urgent social needs we found that generic conditions – specifically size rather than wealth – explain why countries are active. Inactive countries are much smaller and have insufficient resources to participate. The six comparative advantages explain why some active countries are specialised and others are not. Specialised countries have fewer resources than non-specialised active countries (but more than inactive countries) and need to be selective. The comparative advantage drives selection. The incidence of infectious diseases is about as high as in the inactive countries, but much higher than in non-specialised active countries: there is more than 10 times as much HIV/AIDS, 17 times as much malaria, and almost 5 times as much tuberculosis.
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